Frequently Asked Questions (FAQs)
Find answers to commonly asked questions related to BATA.
General Information
1. When was the Biological Agents and Toxins Act (BATA) enforced?
The BATA was passed by Parliament on 18 October 2005 and enforced on 3 January 2006.
2. How can the latest version of the Biological Agents and Toxins Act and its regulations be accessed?
Downloading from the Singapore Statutes Online. (opens in new tab)
Subscribing to the LawNet service provided by the Singapore Academy of Law.
Purchasing from the Singapore Government Printer, Toppan Next Pte Ltd through the contact details available at Toppan’s website (opens in new tab).
3. What does the Biological Agents and Toxins Act (BATA) regulate?
The Act regulates the possession, use, import, transhipment, transfer and transportation of biological agents, inactivated biological agents, and toxins that are known to be hazardous to human health in Singapore.
The BATA is a risk-based legislation that sets stringent controls on biological agents and toxins that pose high or significant risk to public health, safety and security, and less stringent controls on biological agents with a moderate risk profile. Biological agents which are of negligible risk to public health, safety and security are not regulated.
4. What are the risk characteristics of the scheduled biological agents and toxins in the Biological Agents and Toxins Act (BATA)?
There are five schedules of biological agents and toxins in the BATA, and the table below shows an overview of the Schedules with their corresponding risks.
Overview of the Schedules with their corresponding risks
Description of Risk | |
First Schedule Part 1 | Risk Group 3 biological agents that usually cause serious human disease, and some may spread within the community. Effective treatments or preventive measures are usually available. Part 2 biological agents are perceived to have the potential to be weaponised. |
First Schedule Part 2 | |
Second Schedule | Risk group 4 biological agents that usually cause serious or lethal human disease and may be readily transmitted from person-to-person. Effective treatments and/or preventive measures are not usually available. Such biological agents are perceived to have the potential to be weaponised. |
Third Schedule | Risk group 2 biological agents that needs special attention if produced in large scale. |
Fourth Schedule | Harmful biological agents (to human health) that are not a First or Second Schedule biological agent, i.e. risk group 2 biological agents that can cause disease in humans but is unlikely to pose serious hazard, albeit some may present risk of spreading to the community. Effective treatments and/or preventive measures are available. |
Fifth Schedule | Selected microbial toxins that perceived to have the potential to be weaponised. |
5. What are the requirements to possess the scheduled biological agents and toxins regulated under the Biological Agents and Toxins Act?
The table below shows the requirements for the possession of First Schedule and Second Schedule biological agents, and Fifth Schedule toxins:
Requirements for the possession of First Schedule and Second Schedule biological agents, and Fifth Schedule toxins.
Biological Agent / Toxin | Pre-requisite to Possess |
First Schedule Part 1 biological agent |
|
First Schedule Part 2 biological agent |
|
Second Schedule biological agent |
|
Fifth Schedule toxin |
|
6. Where to find the list of the Fourth Schedule biological agents?
Fourth Schedule biological agents cover ALL risk group 2 agents or ALL harmful biological agents (to human health) that are not listed in the First or Second Schedule. The list for Fourth Schedule is non-exhaustive.
To facilitate importation, the more common risk group 2 biological agents are listed under the "Fourth Schedule" of the List of Biological Agents and Toxins (opens in new tab). Importers are advised to use the dummy product code for hazardous biological agent that are not found in the list. Enquiries can be sent to the email available on the Contact Us page.
Note: Check the List of Biological Agents and Toxins (opens in new tab)before submitting any import application, as the list may be updated periodically.
7. Who is covered by the Biological Agents and Toxins Act (BATA)?
The BATA applies to any person or party (laboratory, company or institution, etc) dealing with biological agents and toxins listed in the Schedules of the Act.
Individuals who wish to work with, possess, use, and/or store the biological agents and toxins should be aware of and familiar with the requirements of the Act, as these can affect their operations.
Courier service providers transporting biological agents and toxins within and into Singapore should also be aware of the requirements for transportation, transhipment, and transfer of biological agents and toxins.
8. What activities involving biological agents or toxins are excluded from the Biological Agents and Toxins Act (BATA)?
The BATA does not apply to the following activities:
Disposal of any biological agent by a hazardous waste contractor.
Handling of any biological agent or toxin in the course of carrying out a diagnosis or an autopsy.
Collection of food samples or environment samples for laboratory analysis to determine or identify, for public health purposes.
Use or possession of any finished cosmetic or medicinal product consisting of any toxin by -
Any person lawfully manufacturing, supplying, selling or dispensing the finished cosmetic or medicinal product.
Any registered medical practitioner using the finished cosmetic or medicinal product in the course of treating another person.
Any person using the finished cosmetic or medicinal product for its intended cosmetic or medical purposes.
9. What is the definition of "diagnosis" in the Biological Agents and Toxins Act (BATA)?
The BATA defines "diagnosis" as any activity undertaken solely with the intention of analysing a specimen from a person or an animal in which a biological agent is or is suspected of being present for the purpose of -
Determining the cause of any disease suffered by a person or animal.
Assessing the clinical progress of a person or animal.
Carrying out the clinical management of a person or animal.
Determining the cause of death of a person or animal in an autopsy.
Identifying or determining the nature of the toxin suspected to be present in the specimen for public health purposes.
Note: Any positive specimen, along with any First or Second Schedule biological agent or Fifth Schedule toxin positively identified or isolated, must be destroyed or transferred to a facility with requisite approval as soon as possible after confirmation of diagnostic test results. Approval under BATA is required if diagnostic laboratories intend to possess the biological agent or toxin beyond diagnosis.
10. Must research laboratories be familiar with all requirements for scheduled biological agents and toxins under the Biological Agents and Toxins Act ?
The provisions of the Act depend on the type of biological agent being worked on, rather than the type of laboratory or industry. The schedule of the biological agents or toxins and the work involved will determine which sections of the Biological Agents and Toxins Act (opens in new tab) are applicable.
11. Does the Biological Agents and Toxins Act (BATA) impose any specific requirements for genetically modified micro-organisms (GMMs)?
The BATA does not differentiate GMMs (or genetically modified biological agents or GMBAs) from non-GMMs (on non-GMBAs).
Anyone who intends to work on GMMs or GMBAs should adhere to the Singapore Biosafety Guidelines for Research on Genetically Modified Organisms, conduct a risk assessment, and submit a proposal to the Genetic Modification Advisory Committee (GMAC) for formal endorsement, while keeping the Health Sciences Authority updated.
Note: Visit the Genetic Modification Advisory Committee (opens in new tab) website for more details on the GMAC's framework and guidelines.
12. Which sections of Biological Agents and Toxins Act (BATA) apply to courier service providers handling biological agents and toxins?
Courier service providers must be familiar with the requirements for import, transhipment and transport of biological agents and toxins.
Key responsibilities of couriers include:
Working with their clients to ensuring that valid permits are secured from the Health Sciences Authority before clearance of any import or transhipment.
Ensuring drivers who are transporting First, Second, Third Schedule biological agents or Fifth Schedule toxins have undergone appropriate training and have valid Hazmat Drivers Training Permit.
Ensuring there is no unreasonable delays and protecting the security of the biological agents/toxins during transportation.
Note: Refer to the following sections for more information:
13. What is the difference between Health Sciences Authority (HSA) and Animal Veterinary Service (AVS) regulations for biological agents?
The Biological Agents and Toxins Act (opens in new tab) under HSA, regulates biological agents capable of causing disease in humans (human pathogens), while the Animals and Birds Act (opens in new tab) under AVS controls biological agents capable of causing disease in animals (animal pathogens).
Biological agents causing diseases in both humans and animals (zoonotic pathogens) are jointly regulated by HSA and AVS. Depending on the risk grouping or schedule of the biological agents, each agency may have its own requirements. Refer to the respectively agencies for the requirements.
Note: Refer to Import/Transhipment Permits Guidelines on how to apply for an import permit.
14. Does the Biological Agents and Toxins Act (BATA) regulate the export of biological agents, inactivated biological agents, and toxins listed in the schedules?
The BATA DOES NOT regulate the export of biological agents, inactivated biological agents and toxins.
15. Which agency controls the export of biological agents and toxins?
The exportation of biological agents and toxins is regulated by the Strategic Goods Control Act (opens in new tab) under the Strategic Goods Control Unit of Singapore Customs. If the export involves a First or Second Schedule biological agent, or a Fifth Schedule toxin, the Health Sciences Authority should be notified via the Healthcare Application and Licensing Portal-Biosafety Module (HALP-BS (opens in new tab)).
Approvals and Permits
1. What does the Biological Agents and Toxins (BATA) regulate?
List of approvals and permits under the BATA.
Controls | First Schedule Biological Agent | Second Schedule Biological Agent | Third Schedule Biological Agent | Fourth Schedule Biological Agent | Fifth Schedule Toxin | Inactivated (First and Second Schedule) Biological Agent | |
Part 1 | Part 2 | ||||||
Certified Facility | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ |
Protected Place | ✘ | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ |
Approval to Possess | ✔ | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ |
Large Scale Production1 | ✔ | ✔ | PROHIBITED | ✔ | ✘ | ✘ | ✘ |
Special Approval to Handle | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ |
Import Permit | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
Transhipment Permit | ✔ | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ |
Transfer Notification2 | # | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ |
Failure of Receipt3 | # | ✔ | ✔ | ✘ | ✘ | ✔ | ✘ |
Incident Notification4 | ✔ | ✔ | ✔ | ✔ | # | ✔ | ✔ |
Legend: ✔ = Mandated, # = Encouraged, ✘ = Not Applicable
1 Large Scale Production: Production of a biological agent using equipment capable of producing in aggregate >10 litres of culture at any one time.
2 Transfer Notification: Mandatory for First Schedule Part 2, Second Schedule biological agents, and Fifth Schedule toxins. Highly encouraged for First Schedule Part 1 biological agents.
3 Failure of Receipt Notification: Mandatory for First Schedule Part 2, Second Schedule biological agents, and Fifth Schedule toxins. Highly encouraged for First Schedule Part 1 biological agents.
4 Incident Notification: Mandatory for First, Second, and Third Schedule biological agents and Fifth Schedule toxins. Encouraged for Fourth Schedule biological agents.
2. How to apply for an approval or a permit?
Approval for Possess, Special Approval to Handle, and Approval to Produce (Large Scale Production) can be done online via the Healthcare Application and Licensing Portal-Biosafety Module (HALP-BS) (opens in new tab)
Application for import and transhipment permit is done via the Singapore Customs’ Tradenet Portal (opens in new tab)
Possession
1. What is an Approval to Possess?
An Approval to Possess is granted to a Facility Operator for the possession of First and Second Schedule biological agents or Fifth Schedule toxins. It is required for first-time possession and is specific to the biological agent or toxin. Basic criteria for approval include the following:
Adequate containment measures are in place to mitigate risks to public health, safety and security.
Certified Facility for First Schedule Part 1 biological agents, Certified and Protected Place for First Schedule Part 2 and Second Schedule biological agents; and Protected Place for Fifth Schedule toxins.
Special Approval to Handle for Second Schedule biological agents.
2. What are the requirements for possessing a First Schedule biological agent?
To possess a First Schedule biological agent, the Facility Operator must ensure that his/her facility:
Has been successfully certified/audited by a Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB) as a Certified Facility.
Is gazetted as a Protected Place under the Infrastructure Protection Act (opens in new tab) and meeting the Protective Security Workgroup Guidelines) (opens in new tab), for First Schedule Part 2 biological agent.
Has a risk assessment scheme in place and has implemented the relevant biorisk management systems, and these have been reviewed and approved by the Biosafety Committee and the Facility Operator.
Has obtained Genetic Modification Advisory Committee endorsement for genetically modified biological agent or genetic modification work.
3. What are the requirements for possessing a Second Schedule biological agent?
To possess a Second Schedule biological agent, the Facility Operator must ensure that his/her facility:
Has been successfully certified/audited by a Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB) as a Certified Facility.
Is gazetted as a Protected Place under the Infrastructure Protection Act (opens in new tab) and meeting the Protective Security Workgroup Guidelines (opens in new tab).
Has completed a comprehensive risk assessment on all the activities to be carried out in the facility, and has implemented the relevant biorisk management systems, and these have been reviewed and approved by the Biosafety Committee and the Facility Operator.
Has a Special Approval to Handle the Second Schedule biological agent.
Has obtained Genetic Modification Advisory Committee endorsement for genetically modified biological agent or genetic modification work.
4. What are the requirements for possessing a Fifth Schedule toxin?
To possess a Fifth Schedule toxin, the Facility Operator must ensure that his/her facility:
Has been successfully audited by a Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB) as an Uncertified Facility.
Is gazetted as a Protected Place under the Infrastructure Protection Act (opens in new tab) and meeting the Protective Security Workgroup Guidelines. (opens in new tab)
Has a risk assessment scheme in place and has implemented the relevant biorisk management systems, and these have been reviewed and approved by the Biosafety Committee and the Facility Operator.
5. Does an approval to possess have an expiry date?
Approval to possess does not have an expiry date but is valid as long as the facility remains actively registered as a Certified Facility, Uncertified Facility, or Biomanufacturing Facility with the Health Sciences Authority (HSA) through the Healthcare Application and Licensing Portal-Biosafety Module (HALP-BS (opens in new tab)). HSA reserves the right to revoke approvals under the Biological Agents and Toxins Act.
6. Do diagnostic laboratories need approval to possess First and/or Second Schedule biological agents or Fifth Schedule toxins after diagnosing a positive sample?
Handling biological agents or toxins for diagnosis and autopsy purposes are exempted under the Biological Agents and Toxins Act. (opens in new tab) However, after confirming the diagnosis or autopsy work, the biological agent or toxin together with the samples containing it must be destroyed or transferred to a facility that has the approval to possess the said biological agent or toxin.
If a laboratory or facility intends to retain the biological agent or the toxin, or the samples containing the biological agent or toxin, or perform activities beyond diagnosis or autopsy, the facility must apply for approval to possess from the Health Sciences Authority.
7. Can diagnostic laboratories transfer a sample that has been screened or diagnosed as having a First or Second Schedule biological agent, or a Fifth Schedule toxin to a reference laboratory for independent diagnosis?
Yes, samples can be transferred for diagnosis confirmation. The reference laboratory does not require approval to possess but must destroy the samples after completing the diagnosis.
8. How should facilities proceed with applications to possess zoonotic pathogens jointly controlled by Health Sciences Authority (HSA) and Animal and Veterinary Service (AVS)?
Facilities must apply to both the HSA and AVS (opens in new tab) for approval to possess or license to handle zoonotic pathogens.
9. Is approval required for working with Human Immunodeficiency Virus (HIV) lentiviral vectors?
While HIV lentiviral vectors (HIV-LV) are derived from HIV - a First Schedule Part 1 biological agent under the Biological Agents and Toxins Act (BATA), their risks could be altered by genetic modification. Depending on the extent of genetic modification, HIV-LVs can be classified into:
Fourth Schedule: If the resultant risk is equivalent to or lower than Risk Group 2.
First Schedule Part 1: If the resultant risk is higher than Risk Group 2.
The use of HIV-LVs must comply with BATA requirements for their respective Schedules.
10. How to determine if a Human Immunodeficiency Virus lentiviral vector (HIV-LV) is classified as a First or Fourth Schedule biological agent?
HIV-LVs are classified as Fourth Schedule biological agents if they meet at least TWO of the following criteria:
U3 region of the 3'LTR in the transfer vector is absent or altered, creating a stable self-inactivating (SIN) configuration.
Packaging genes are split across at least two plasmids (excluding the env plasmid).
vpr, vpu, vif and nef genes are absent or non-functional.
The vector system requires at least four recombination events to achieve Replication Competent Lentivirus.
Any HIV lentiviral vector that does not satisfy the above definition will be categorised as a First Schedule biological agent.
Special Approval to Handle
1. What is a Special Approval to Handle?
Special Approval to Handle applies only to Second Schedule biological agents. Applications will only be considered if:
The use of the biological agent is necessary for public interest.
Adequate measures are implemented to contain the risk to public health, safety, and security.
2. How to apply for a Special Approval to Handle?
Submit the following documents to Health Sciences Authority (HSA) via the Healthcare Application and Licensing Portal-Biosafety Module (HALP-BS (opens in new tab)):
Formal justifications for using the biological agent.
Proof of facility is a Certified Facility.
Proof of facility is gazetted as a Protected Place under the Infrastructure Protection Act (opens in new tab) and meeting the Protective Security Working Group Guidelines) (opens in new tab).
Details of the work or activities, risk assessments and mitigation measures that have been reviewed and approved by the Biosafety Committee and the Facility Operator.
Any other information and documents requested by HSA.
Large-scale Production
1. What is Large-scale Production?
Large-scale Production involves producing biological agents using equipment capable of aggregating 10 or more litres at any one time.
2. Which application should come first, Approval to Large-scale Produce or Approval to Possess?
First Schedule biological agents: Apply for approval to possess first, then proceed with approval to large-scale produce.
Third Schedule biological agents: Directly apply for approval to large-scale produce, as possession approval is not required.
3. How to apply for a Large-scale Production?
Submit the following documents to Health Sciences Authority (HSA) via the Healthcare Application and Licensing Portal-Biosafety Module (HALP-BS (opens in new tab)):
Formal justifications for using the biological agent.
Proof of facility is a Certified Facility, Uncertified Facility or Biomanufacturing Facility.*
Proof of facility is gazetted as a Protected Place under the Infrastructure Protection Act (opens in new tab) and meeting the Protective Security Working Group Guidelines (opens in new tab); if First Schedule Part 2 biological agents and Fifth Schedule toxins are involved.
Details of the work or activities, risk assessments and mitigation measures.
Any other information and documents requested by HSA.
*Refer to the respective section to understand which type of facilities is required for the large-scale production work.
4. Does the approval to large-scale produce have an expiry date?
The validity of the approval is tied to:
A valid Approval to Possess (for First Schedule biological agents or Fifth Schedule toxins).
Active registration of the facility as Certified Facility, Uncertified Facility or Biomanufacturing Facility in Healthcare Application and Licensing Portal-Biosafety Module, HALP-BS (opens in new tab).
Production at the facility specified in the approval.
Compliance with conditions stipulated in the approval, which may include an expiry date.
Note: The Health Sciences Authority retains the right to revoke any approval granted under the Biological Agents and Toxins Act.
5. Is Large-scale Production prohibited for any of the schedules?
Yes, it is prohibited for Second Schedule biological agents.
Inactivation of First and Second Schedule Biological Agent
1. Can a facility without possession approval work with inactivated (First and/or Second Schedule) biological agents?
Yes, provided the inactivated (First and/or Second Schedule) biological agent is -
Supplied by a local facility authorised to perform inactivation of the biological agent using validated procedures; or
Imported with proof of successful inactivation.
Facilities must treat the inactivated biological agents as potentially infectious and notify Health Sciences Authority (HSA) immediately if live or replication competent biological agents are suspected.
2. What are the conditions for performing inactivation (of First and/or Second Schedule) biological agents?
Before performing any inactivation activities, the Facility Operator must ensure that:
His/her facility has a valid Approval to Possess the biological agent.
The inactivation procedures have been validated with documented efficacy.
The Biosafety Committee has reviewed and endorsed the inactivation procedures and the validation results.
The inactivation procedures are performed at the approved facility.
Monitoring systems are in place to ensure continued efficacy of the inactivation procedures.
3. What supporting documents are required for applying import permit for inactivated (First and/or Second Schedule) biological agents?
Submit the following documents to Health Sciences Authority (HSA) via the email available on the Contact Us page:
Source and institution details of the inactivated biological agent.
Credential of the person performing inactivation.
Inactivation method/procedures and validation report.
Biosafety Committee approval with risk assessment.
Research proposal or activities details on the inactivated biological agent.
Any other documents requested by HSA.
4. Does Health Sciences Authority (HSA) provide approved inactivation methods?
HSA reviews inactivation methods on a case-by-case basis but does not provide specific methods.
Risk Assessment
1. Is risk assessment a requirement under the Biological Agents and Toxins Act?
Yes, Sections 39 and 41 of the Biological Agents and Toxins Act (opens in new tab) mandate risk assessments for all activities conducted in the facility.
2. When should risk assessments be conducted?
Risk assessment should be conducted before commencement of any work and subsequently under any of the conditions below, whichever is earlier:
Changes in work processes, equipment or workplace conditions/layout.
After accidents, near misses, or dangerous acts.
Every 2 years.
3. Who should conduct risk assessment?
The Biosafety Committee (comprising members with appropriate expertise), appointed by the Facility Operator, is responsibility to conduct risk assessments. The committee shall formulates policies, programmes, codes of practices and devises risk management measures to ensure activities can be carried out safely before approving their commencement.
4. Are there guidelines for performing risk assessments?
Refer to the Guidelines on Laboratory/Work Risk Assessment (opens in new tab) for instructions.
Import/ Transhipment Permits
1. Do all biological agents and toxins listed in the Biological Agents and Toxins Act (BATA) require import/ transhipment permits?
Import permits: Required for all biological agents and toxins listed in the First, Second, Fourth and Fifth Schedules, including inactivated (First and Second Schedule) biological agents.
Transhipment permits: Required for biological agents and toxins listed in the First, Second and Fifth Schedules.
2. Is a permit required for unlisted biological agents or toxins?
Some unlisted biological agents or toxins may require permits, especially biological agents that can cause disease in human. If unsure, contact Health Sciences Authority via the email available on the Contact Us page for advice.
3. How can facilities apply for import/ transhipment permits?
Facilities can apply the permit online via the Singapore Customs’ Tradenet Portal (opens in new tab), preferable 5 working days before arrival.
For facilities with a Tradenet Portal account: Apply directly.
For facilities without a Tradenet Portal account: Engage a courier service provider with a Tradenet account. Ensure all information provided to the service provider (e.g. UEN/CRN of your institute or facility, HS and HSA product code, etc.) is accurate and verify the permit is valid before clearance of the consignment with customs.
4. What information and documents are required for applying an import permit?
Information/documents required include:
HS code and HSA product code (and AVS product code for zoonotic pathogens) which can be found in the List of Biological Agents and Toxins. (opens in new tab)
Unique Entity Number (UEN) or Central Registration Number (CRN) of the declarant’s company.
Declarant and declarant’s company details (name, address, and contact).
Importer’s name and address.
Commercial Invoice and Airway Bill.
Additional information/documents requested by HSA.
For inactivated First and Second biological agents, the additional information/documents required are -
Person performed the inactivation.
Facility performed the inactivation.
Inactivation method or procedures.
Inactivation validation report.
A formal signed declaration letter from importer and/or the end-user facility.
Note: For biological agents and toxins listed in First, Second and Fifth Schedules, the application procedures are slightly different. If unfamiliar with the procedures, contact HSA (via the email available on the Contact Us page) before submitting the application.
5. What information and documents are required for applying a transhipment permit?
Information/documents required include:
HS code and HSA product code (and AVS product code for zoonotic pathogens) which can be found in the List of Biological Agents and Toxins (opens in new tab).
Unique Entity Number (UEN) or Central Registration Number (CRN) of the declarant’s company.
Declarant and declarant’s company details (name, address and contact)
Commercial Invoice and Airway Bill.
Transhipment handling agent name.
Departure date from Singapore.
Storage location in Singapore while waiting for transhipment.
Additional information/documents requested by HSA.
Note: For biological agents and toxins listed in First, Second and Fifth Schedules, the application procedures are slightly different. If unfamiliar with the procedures, contact HSA (via the email available on the Contact Us page) before submitting the application.
6. Who is responsible for obtaining an import/ transhipment permit?
The importer/transhipper (the facility or end user of the biological agent or the toxin) is responsible for obtaining a valid permit, even if a courier service provider is engaged. The importer shall provide accurate information/document to the service provider for the application, and to verify the validity of the permit (e.g. by requiring the service provider to fax or email the permit for verification) before clearing the consignment with customs.
7. Which come first, approval to possess or import permit for biological agents or toxins listed in the First, Second or Fifth Schedule?
Apply for Approval to Possess first. Once granted, apply for the import permit.
8. What is an Import Specific Product (ISP) code?
ISP codes are issued to specific facilities for regular imports of proficiency panels or biological materials with fixed schedules from specific source or locations. They replace the HSA product code in import permit applications but are NOT permits themselves.
9. What is the validity of an Import Specific Product (ISP) code?
ISP codes are valid for up to 5 years. To reduce confusion, all ISP codes for a facility is aligned to a single expiry date. Thus, ISP codes issued to a specific facility at different time points will have a same expiry date but different validity periods.
10. How to apply for import/ transhipment permit for zoonotic pathogens?
Refer to Questions 3, 4 and 5 in this section for details.
11. Is an import permit required for diagnostic test kits?
Generally, no permit is required as most controls in diagnostic kits are inactivated. However, if the kit contains highly infectious biological agents, consult Health Sciences Authority (via the email available on the Contact Us page) as a permit may then be needed.
12. What are the packaging requirements for importation/ transhipment of biological agents and toxins?
Packaging (and labelling) must comply with the Biological Agents and Toxins (Transportation) Regulations (opens in new tab), and for air transport, the International Air Transport Association (IATA) (opens in new tab) Dangerous Goods Regulations apply.
Healthcare Application and Licensing Portal (HALP)
1. What is the Healthcare Application and Licensing Portal-Biosafety module (HALP-BS)?
Healthcare and Licesing Portal-Biosafety Module (HALP-BS (opens in new tab)) is an e-services portal for Facility Operators or Service Providing Companies to register themselves with Health Sciences Authority (HSA) for:
Approvals related to biological agents and toxins.
Handling of Fifth Schedule toxins for exempted activities.
Retaining/handling of materials positive or potentially positive for Sabin poliovirus.
Providing certification/audit services as an Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB) and Certifier.
2. What are the requirements to access HALP-BS?
Having a valid CorpPass access to HALP-BS. This access is enabled by the individuals’ company CorpPass Administrator; and
Having an active account with HALP-BS. The account is created or activated by the individuals’ company Master Admin.
3. What are the roles and functions of the different personnel in HALP-BS?
Refer to the table below for the functions available to each role in the HALP-BS:
Function/Roles | Master | Master Admin with | Facility Administrator | Alternate Administrator | Facility Officer | |
User Management | Create new | ✔ | ✔ | ✘ | ✘ | ✘ |
Create facility assignment | ✔ | ✔ | ✘ | ✘ | ✘ | |
Terminate/remove facility assignment | ✔ | ✔ | ✘ | ✘ | ✘ | |
Edit user roles | ✔ | ✔ | ✘ | ✘ | ✘ | |
Inactivate/Reactivate user account | ✔ | ✔ | ✘ | ✘ | ✘ | |
Facility Registration | Register New Facility | ✔ | ✔ | ✔ | ✔ | ✘ |
Renew Facility Registration | ✘ | ✔ | ✔ | ✔ | ✘ | |
Update Facility Registration | ✘ | ✔ | ✔ | ✔ | ✔ | |
Deregister Facility | ✘ | ✔ | ✔ | ✔ | ✘ | |
Withdrawal Application related to Facility Registration | ✘ | ✔ | ✔ | ✔ | ✔ (limiting to submission related to 'Update Facility Registration') | |
Approvals Application | Application for Approval for Facility Activity Type | ✘ | ✔ | ✔ | ✔ | ✘ |
Application for Approval to Possess | ✘ | ✔ | ✔ | ✔ | ✘ | |
Application for Special Approval to Handle | ✘ | ✔ | ✔ | ✔ | ✘ | |
Application for Approval to Large-scale Produce | ✘ | ✔ | ✔ | ✔ | ✘ | |
Update Approval | ✘ | ✔ | ✔ | ✔ | ✔ | |
Data Submission | Request for Transfer | ✘ | ✔ | ✔ | ✔ | ✔ |
Transfer | ✘ | ✔ | ✔ | ✔ | ✔ | |
Acknowledge Receipt of Transfer | ✘ | ✔ | ✔ | ✔ | ✔ | |
Export | ✘ | ✔ | ✔ | ✔ | ✔ | |
Receipt of Biological Agent/Toxin from a Non-registered Facility | ✘ | ✔ | ✔ | ✔ | ✔ | |
Disposal of stock | ✘ | ✔ | ✔ | ✔ | ✔ | |
Inventory Adjustment | ✘ | ✔ | ✔ | ✔ | ✔ | |
Facility Data Submission | ✘ | ✔ | ✔ | ✔ | ✔ | |
Reportable Events | Incident Notification | ✘ | ✔ | ✔ | ✔ | ✔ |
Investigation Report and follow-up | ✘ | ✔ | ✔ | ✔ | ✔ | |
View Incident Report | ✘ | ✔ | ✔ | ✔ | ✔ | |
4. What are the procedures for changing the Facility Admin?
Following are the steps to change the Facility Admin. The Master Admin must:
First create a HALP-BS account for the incoming Facility Admin (if he/she is not an existing user) and assign the role.
Then, set the effective start date for the incoming Facility Admin and the end date for the outgoing Facility Admin.
Note: The effective start date of the incoming Facility Admin must be after the end date for the outgoing Facility Admin.
Update the Facility Registration to reflect the changes.
Similar steps apply for changing the Alternate Admin.
5. Is there guidance on using HALP-BS?
Refer to HALP-BS user guides for the detailed procedures on the usage of the portal.
Notification
1. What types of notification can be submitted via Healthcare Application and Licensing Portal-Biosafety Module (HALP-BS)?
Notifications that can be submitted via the Healthcare Application and Licensing Portal-Biosafety Module (HALP-BS) (opens in new tab)include:
Transfer and receipt of biological agents/toxins.
Failure of receipt biological agents/toxins.
Disposal of biological agents/toxins stocks.
Export of biological agent/toxins.
Incident (e.g. injury, infection, loss or environmental release of biological agents/toxins).
2. Who needs to submit a notification of Transfer?
Both sender and receiver must submit notifications of Transfer (opens in new tab) of biological agents/toxins under the First, Second and Fifth Schedules.
Sender and receiver must submit notification of transfer and receipt, respectively in HALP-BS, (opens in new tab) if both are facilities registered with HALP-BS.
If sender is a local facility not registered with HALP-BS, the sender is to notify Health Sciences Authority about the transfer via the email available on the Contact Us page. The receiver, who must be a registered facility, must submit a “notification of receipt from a non-registered facility" via the HALP-BS (opens in new tab)
3. What is "Failure of Receipt"?
Failure of Receipt refers to the non-arrival of biological agents/toxins within 24 hours of such time or as they are reasonably estimated to be arrived, whether through local transfer or importation.
4. How to submit a Notification of Failure to Receive?
Notify Health Sciences Authority via email (available on the Contact Us page), followed by a submission of Notification of Failure to Receive (of biological agents and toxins listed in First, Second or Fifth Schedules) via the HALP-BS (opens in new tab)
5. What incidents must be notified under the Biological Agents and Toxins Act (BATA)?
Incidents required notification include:
Confirmed or suspected infections or illnesses acquired during handling of activities involving biological agents/toxins in the facility.
Adverse incidents involving biological agents/toxins.
Loss or theft of biological agents/toxins.
Destruction of stocks for First and Second Schedule biological agents, and Fifth Schedule toxins.
6. What is the difference between "Notification of Complete Destruction/Disposal" and "Notification of Consumption" of biological agents/toxins?
Complete Disposal/Destruction: All stocks are destroyed/inactivated and the item is removed from the inventory.
Consumption: Partial use/disposal of stocks, with remaining inventory retained.
7. What should be done if an incident notification cannot be submitted through HALP-BS?
Send the incident notification via e-mail available on the Contact Us page, then submit the online notification in HALP-BS, (opens in new tab) once possible.
8. Is there any follow-up after the submission of an incident report?
Yes, conduct a thorough investigation, follow-up on affected staff, and submit the investigation report with corrective/preventive actions via the HALP-BS (opens in new tab)
Certified Facility
1. What is a Certified Facility?
A Certified Facility is a high or maximum containment facility certified/audited by a Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB) to meet biorisk (biosafety and biosecurity) management requirements for handling high-risk (i.e. First Schedule and Second Schedule) biological agents.
2. Which facilities require certification under the Biological Agents and Toxins Act?
Facilities handling First and Second Schedule biological agents must be certified/audited by a Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB). Certification is required for new facilities post-commissioning and must be renewed annually or after any design or structural change, whichever is earlier.
3. Which facilities need to be gazetted as a Protected Place under the Infrastructure Protection Act?
Facilities handling First Schedule Part 2 biological agents, Second Schedule biological agents, or Fifth Schedule toxins must be gazetted as Protected Place under the Infrastructure Protection Act (opens in new tab).
To initiate the process, submit a justification letter to Health Sciences Authority (HSA) for support, then apply to the relevant authority with HSA’s support letter. Detailed procedures are available in the Application for Gazette or De-gazette as a Protected Place (opens in new tab)
4. What information and documents are required for registering or renewing a Certified Facility with Health Sciences Authority (HSA)?
The information/documents required include:
Facility layout and air-conditioning and mechanical ventilation (ACMV) schematics.
Facility administrative oversight plan and biorisk (biosafety and biosecurity) management manual.
Biosafety Committee and Biosafety Coordinator meeting Biological Agents and Toxins Act (BATA) requirements.
List of personnel working in the facility.
Certification/audit report.
Relevant authority approvals (e.g. Public Utilities Board's approval for discharge of trade effluent into public sewage).
Any other documents requested by HSA.
For Certified Facilities that are required to be a Protected Place (e.g. possessing and handling of First Schedule Part 2 biological agents and Fifth Schedule toxins), additional documents, i.e. the Protected Place gazette document (the Singapore Government Gazette published announcement) and completed Protective Security Work Group checklist are also required.
5. What reference materials are used for the certification/audit?
For High Containment (BSL3) Facility: Singapore Standard (SS696:2023) Specification for High Containment (Biosafety Level 3) Facility (opens in new tab) and the corresponding checklist (opens in new tab)
For Maximum Containment (BSL4) Facility: Biosafety Standard for Maximum Containment (Biosafety Level 4) Facility (opens in new tab)
6. Does an Animal Biosafety Level 3 (ABSL3) facility require certification and registration with Health Sciences Authority (HSA)?
Yes, if the ABSL3 facility handling or storing live BATA First and Second Schedule biological agents.
7. Is pre-certification/audit verification required before re-certification/audit of a facility by the Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB)?
While HSA requires annual certification/audit by an HSA-AFCB, pre-certification verification is at the discretion of the Facility Operator.
8. Should a facility shut down for the certification/audit?
Shutting down allows safe access, robust testing, and maintenance opportunities of the facility. Facility Operator should assess the need for its facility based on safety, facility conditions, and operational impacts.
Note: Shut down includes stopping all laboratory activities, storage of all biological agents and toxins in a safe and secure manner, and complete decontamination of the facility.
9. What if the facility is not shut down for certification/audit?
Facility personnel must:
Work with the Biosafety Committee to conduct a comprehensive risk assessment.
Implement proper safety measures to protect all personnel who may participate in the maintenance and certification/audit of the facility.
Obtain Facility Operator’s approval, and agreement from the service crew and the appointed Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB) to conduct facility maintenance and certification/audit services in a “non-shut down” condition.
Notify Health Sciences Authority of the decision via email (available on the Contact Us page) at least 1.5 months in advance.
Uncertified Facility
1. What is an Uncertified Facility?
An Uncertified Facility is a Biosafety Level 2 (BSL2) facility with enhanced biorisk (biosafety and biosecurity) management measures and is approved by Health Sciences Authority to possess Fifth Schedule toxins, handle Third Schedule biological agents, or possess and perform low risk activities on materials containing First Schedule biological agents. Facilities handling First Schedule Part 2 biological agents or Fifth Schedule toxins are also required to be gazetted as Protected Places under the Infrastructure Protection Act (opens in new tab) and meeting the Protective Security Working Group Guidelines (opens in new tab)
2. Is an Uncertified Facility required to undergo certification/audit?
Yes, Uncertified Facilities must undergo compliance (biosafety and biosecurity) verification audit by a Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB) before the granting of approval to possess materials positive for First Schedule biological agents or Fifth Schedule toxins or large-scale produce Third Schedule biological agents. Biennial or triennial renewal audit is required based on HSA’s risk assessment.
3. What are the information and documents required for registering an Uncertified Facility with Health Sciences Authority (HSA)?
The information/documents required include:
Facility layout and biosafety level.
Facility administrative oversight plan and biorisk (biosafety and biosecurity) management manual.
Type of approval (e.g. possession and/or large-scale production).
Details of the biological agent or toxin (e.g. name, characteristic and risk level), the materials (e.g. nature of the biological agent or toxin) and the associated activities.
Risk assessment and biosafety and biosecurity measures for safe and secure handling of the biological agent or toxin.
Biosafety Committee and biosafety coordinator meeting the requirement in the Biological Agents and Toxins Act. (opens in new tab)(BATA) requirements.
List of personnel working in the facility.
Audit report.
Any other information/documents requested by HSA.
For Uncertified Facilities that required to be Protected Places (e.g. possessing and handling of First Schedule Part 2 biological agents and Fifth Schedule toxins), additional documents, i.e. the protected place gazette document (the Singapore Government Gazette published announcement) and completed Protective Security Work Group checklist are also required.
Biomanufacturing Facility
1. What is a biomanufacturing facility?
A Biomanufacturing Facility generally refers to a facility involved in the use of large quantities of cells or other biological agents or materials to produce commercially products such as vaccines, monoclonal antibodies, and proteins for medicinal use.
2. Are biomanufacturing facilities regulated under the Biological Agents and Toxins Act (BATA)?
Yes. BATA applies to a biomanufacturing facility that possesses or handles First or Second Schedule biological agents or Fifth Schedule toxins, or carries out large-scale production of First or Third Schedule biological agents.
3. What are the criteria to determine if a large-scale production facility should be registered as a biomanufacturing, certified or uncertified facility with Health Sciences Authority under the Biological Agents and Toxins Act?
Facility registration criteria
Schedule of Biological Agent to be Produced in Large-scale | Need to Comply with GMP* and/or the Health Products Act (opens in new tab) | Type of Facility Registration | Protected Place Requirement |
First Schedule Part 1 | Yes | Biomanufacturing facility | No |
No | Certified facility | No | |
First Schedule Part 2 | Yes | Biomanufacturing facility | Yes |
No | Certified facility | Yes | |
Third Schedule | Yes | Biomanufacturing facility | No |
No | Uncertified facility | No | |
Multiple/Mixed Schedules | Yes | Biomanufacturing facility | Yes, if First Schedule Part 2 biological agent is involved |
No | Certified facility, if First Schedule biological agents are involved | Yes, if First Schedule Part 2 biological agent is involved | |
No | Uncertified facility, if only Third Schedule biological agents are involved | No |
*GMP: Good Manufacturing Practices
4. Is a biomanufacturing facility required to undergo certification/audit?
Yes, biomanufacturing facilities are required to undergo compliance (biosafety and biosecurity) certification/audit by a Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB) before approval to possess any First Schedule biological agents or Fifth Schedule toxins, or to large-scale produce First or Third Schedule biological agents. Subsequently, annual, biennial or triennial renewal certifications/audits are required based on HSA's risk assessment. Facilities possessing and/or handling First Schedule Part 2 biological agents or Fifth Schedule toxins must also be gazetted as Protected Places under the Infrastructure Protection Act (opens in new tab)and meeting the Protective Security Working Group Guidelines (opens in new tab)
5. What are the information and documents required for registering a biomanufacturing facility with Health Sciences Authority (HSA)?
The information/documents required include:
Facility layout and air-conditioning and mechanical ventilation (ACMV) schematics.
Facility administrative oversight plan and biorisk (biosafety and biosecurity) management manual.
Type of approval (possession and/or large-scale production).
Details of the biological agents or toxins (e.g. name, characteristic and risk level) and the associated activities.
Risk assessment and biosafety and biosecurity measures for safe and secure handling of the biological agents or toxins.
Biosafety Committee and biosafety coordinator meeting the requirements in the Biological Agents and Toxins Act (opens in new tab)(BATA).
List of personnel working in the facility.
Characteristics and risk group of the biological agent or the materials.
List of activities to be carried out on the biological agent or the materials.
Audit report.
Any other documents requested by HSA.
For facilities that are also Protected Places (e.g. possessing and handling of First Schedule Part 2 biological agents and Fifth Schedule toxins), additional documents, i.e. the protected place gazette document (the Singapore Government Gazette published announcement) and completed Protective Security Work Group checklist are required.
Facility Certification Body and Facility Certifier
1. What is a Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB) and HSA-Approved Facility Certifier (HSA-AFC)?
HSA-AFCB: Independent company approved by HSA to provide biocontainment facility certification/audit services.
HSA-AFC: Individual certifier engaged by an HSA-AFCB, approved by HSA as their experience and credibility in certifying/auditing biocontainment facilities.
2. What are the criteria for being a Health Sciences Authority-Approved Facility Certification Body and HSA-Approved Facility Certifier?
Detailed requirements are available on Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB) page.
3. How to apply to be a Health Sciences Authority-Approved Facility Certification Body or HSA-Approved Facility Certifier?
Apply online via the Healthcare Application and Licensing Portal-Biosafety Module (HALP-BS). (opens in new tab)
4. Is there a list of Health Sciences Authority-Approved Facility Certification Body and Approved Certifiers to certify/audit my facility?
The list is available on the List of Health Sciences Authority-Approved Facility Certification Body (opens in new tab) page.
5. Can certification/audit services be engaged from a company not listed as a Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB)?
For non-listed companies, provide details of the companies and the certifiers to Health Sciences Authority (via the email available at the Contact Us page) for review. If HSA assessed the companies to be suitable, HSA would invite them to apply to be HSA-AFCB. Once approved, the companies will be included in the List of Health Sciences Authority-Approved Facility Certification Body (opens in new tab)
6. Can a Health Sciences Authority-Approved Facility Certification Body (HSA-AFCB) adding new members to its’ certification team?
Yes, but this will subject to HSA's review and approval. The HSA-AFCB status may be suspended while pending the review.
Protected Place
1. What is a Protected Place?
Premises declared as a Protected Place as defined in section 14 of the Infrastructure Protection Act (opens in new tab)
2. Which biological agents/toxins under the Biological Agents and Toxins Act require a facility to be gazetted as a Protected Place?
Facilities possession/handling First Schedule Part 2, Second Schedule biological agents, or Fifth Schedule Toxins.
3. How to get a facility gazetted as a Protected Place?
Refer to the 'Application for Gazette or De-Gazette as a Protected Place and Personnel Vetting (opens in new tab) page for procedures.
4. What documents are required for submission to Health Sciences Authority (HSA) as proof of Protected Place status?
Singapore Government Gazette published announcement.
Completed Protective Security Working Group Checklist.
Any other document requested by HSA.
5. Are staff working in Protected Place required to be security cleared?
Yes, by the relevant regulatory authority.
6. How can staff be security cleared?
Please follow procedures described in the Application for Gazette or De-Gazette as a Protected Place and Personnel Vetting (opens in new tab)
7. Do visitors and short-term staff (e.g. less than 3 months) need security clearance?
No, but they must be always accompanied by security-cleared personnel when they are in the Protected Place.
8. How should visitors and non-security cleared staff entries be recorded?
At a minimum, the name of the visitor or non-security-cleared staff member, the accompanying security-cleared staff member, the date and time of entry/exit, and the purpose of the visit should be recorded.
9. How to update Health Sciences Authority on changes to security-cleared staff?
Use the “Update Profile” function in Healthcare Application and Licensing Portal-Biosafety Module (HALP-BS (opens in new tab)) to make changes.
10. Can a facility be de-gazetted as a Protected Place?
Yes, facility that no longer possess First Schedule Part 2, Second Schedule biological agents, or Fifth Schedule toxins can initiate the de-gazetting process by following the procedures in the Application for Gazette or De-Gazette as a Protected Place and Personnel Vetting (opens in new tab)
Transportation
1. What are the vehicle requirements for transporting biological agents/toxins?
Requirements:
Item transported | Label | |
Biohazard Sign | Toxic Sign | |
First and Second Schedule biological agents | ✔ | ✘ |
Fifth Schedule toxins | ✘ | ✔ |
First and Second Schedule biological agents and Fifth Schedule toxins | ✔ | ✔ |
Third Schedule biological agents | ✔ | ✘ |
Refer to the Biological Agents and Toxins Act (Transportation) Regulations (opens in new tab) for more details.
2. Does the driver need training to transport biological agents/toxins?
Yes, drivers transporting First, Second, Third Schedule biological agents and Fifth Schedule toxins must have a valid Hazmat Transport Driver Permit (HTDP - Biologicals).
Please forward all enquiries regarding HTDP training to scdf_cda@scdf.gov.sg.
3. Can researchers use personal vehicle for transportation of biological agents/toxins?
Yes, provided that the vehicle is appropriately labelled, the researcher holds a valid Hazardous Materials Transportation Driver Permit (HTDP-Biologicals), and the vehicle is NOT used as public transport.
Note: “Public transport” includes any publicly pr privately operated conveyance that provides general or specialised services to the public on a regular and continuing basis.
4. What should the driver do in case of an emergency incident (e.g. spillage or leakage)?
Cordon off the area, notify the supervisor and owner of the biological agents/toxins, Singapore Civil Defence Force and Health Sciences Authority.
5. What are the packaging requirements for transportation?
Packaging of biological agents/toxins must comply with the Biological Agents and Toxins Act (Transportation) Regulations (opens in new tab) and 24-hour emergency contact details must be clearly displayed on the outer package.
6. What modes of transportation are prohibited?
Mail and public transport are strictly prohibited for biological agents/inactivated biological agents/toxins.
Transfer of Biological Agent and Toxin between Facilities within Singapore
1. Can First, Second and Fifth Schedule biological agents/toxins be transferred between research laboratories or facilities?
Yes, transfer of First and Second Schedule biological agents and Fifth Schedule toxins are allowed under the Biological Agents and Toxins Act, provided:
Both transferor (sender) and transferee (recipient) have valid Approvals to Possess the biological agents/toxins.
Transferor notifies Health Sciences Authority (HSA) via Healthcare Application and Licensing Portal-Biosafety Module (HALP-BS (opens in new tab)) and informs the transferee of the transfer timing.
Transferor ensures that the biological agents/toxins are packed and transported per Biological Agents and Toxins Act (Transportation) Regulations. (opens in new tab)
Transferor provides the carrier with a 24-hour emergency contact number.
Transferee acknowledges receipt in HALP-BS (opens in new tab) within 24 hours or notifies HSA of failure to receive.
2. Can a diagnostic laboratory transfer samples positive for First Schedule, Second Schedule biological agents or Fifth Schedule toxins to another facility for non-diagnostic purposes?
Yes, with the following conditions:
Transferor (sender) must ensure transferee (recipient) has approval to possess the biological agent/toxin.
Transferor notifies Health Sciences Authority (HSA) of the transfer via email available at the Contact Us page and informs the transferee of the transfer timing.
Transferor ensures that the biological agents/toxins are packed and transported per Biological Agents and Toxins Act (Transportation) Regulations. (opens in new tab)
Transferor provides the carrier with a 24-hour emergency contact number.
Transferee acknowledges receipt in HALP-BS (opens in new tab) within 24 hours or notifies HSA of failure to receive.
3. What should be done if a consignment fails to arrive at the expected time?
Transferee (recipient) must notify Health Sciences Authority (HSA) of the failure to receive within 24 hours of the expected arrival time. This applies to First Schedule Part 2, Second Schedule biological agents, and Fifth Schedule toxins. Notifications for other biological agents/toxins are encouraged for public health and safety.
Training Requirements for Staff Working in a Laboratory
1. What are the training requirements for biosafety coordinators in facilities possessing First, Second Schedule biological agents, Fifth Schedule toxins, and facilities conducting large-scale production of Third Schedule biological agents?
Biosafety coordinators must attend and passed a structured course conducted by Health Sciences Authority-Approved Training Providers, which include:
Asia-Pacific Biosafety Association (A-PBA): Biosafety Management Course (2006 - 2020).
National University of Singapore Yong Loo Lin School of Medicine (BSL3 Core Facility): Professional Biorisk Management Course (2021 – 2026).
2. Are training courses other than the above (see question 1) be acceptable for biosafety coordinators?
For training courses other than the above, submit the courses details and proof of participation to Health Sciences Authority (via the email available on the Contact Us page) for case-by-case review.
3. What are the training requirements for staff handling First, Second and Third Schedule biological agents, or Fifth Schedule toxins?
Facilities (with advice from Biosafety Committee) must establish structured training programme with defined competency requirements for staff.
Training should include training before placement, refresher training, and continuous education.
Trainings can be conducted in-house by knowledgeable and experienced staff, or by sending staff to attend relevant external training courses.
Training records (and competency assessment) of all staff shall be properly maintained.
